Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking ...

Currently, C. difficile is first treated with antibiotics like vancomycin, against which the bacteria has not developed a resistance. Fecal transplant only is employed to fight repeated infections, ...

The bacterium Clostridioides difficle, or C. diff, is an urgent antibiotic resistance threat, causing half a million illnesses in the United States each year and nearly 30,000 deaths, according to the ...

TOPLINE: Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in ...

Recent estimates suggest C. difficile approaches 500,000 infections annually in the U.S. and is associated with approximately 20,000 deaths annually. (Guh, 2020, New England Journal of Medicine).

Tesla's new car sales in Europe fell 27.9% in May from a year earlier even as fully-electric vehicle sales in the region jumped 27.2%, with the U.S. EV maker's revised Model Y yet to show signs of ...

If it's severe, your doctor might recommend stopping antibiotics until the diarrhea improves. C. diff diarrhea can take longer to clear up, and it may come back after you treat it. [4] ...

For example, some C. diff cells have flagella, long wiggly appendages that help them move around, while others don’t. This makes choosing a target for a vaccine tricky.

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating it, and patients often experience reinfection, which can be deadly.

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating it, and patients often experience reinfection, which can be deadly.